Shingles vaccine, Shingrix, gets FDA approval for prevention in immunocompromised adults
by Press Release from Outbreak News Today on (#5MMWF)
NewsDesk @bactiman63 GlaxoSmithKline today announced that the US Food and Drug Administration (FDA) has approved Shingrix (Zoster Vaccine Recombinant, Adjuvanted) for the prevention of shingles (herpes zoster) in adults aged 18 years and older who are or who will be at increased risk of shingles due to immunodeficiency or immunosuppression caused by known disease or [...]
The post Shingles vaccine, Shingrix, gets FDA approval for prevention in immunocompromised adults appeared first on Outbreak News Today.